Proteína C (Portuguese Wikipedia)
Analysis of information sources in references of the Wikipedia article "Proteína C" in Portuguese language version.
refsWebsite
Global rank
Portuguese rank
5th place
5th place
doi.org
dx.doi.org
- Nicolaes GA, Dahlbäck B (fevereiro de 2003). «Congenital and acquired activated protein C resistance». Seminars in Vascular Medicine. 3 (1): 33–46. PMID 15199491. doi:10.1055/s-2003-38331
- Foster DC, Yoshitake S, Davie EW (julho de 1985). «The nucleotide sequence of the gene for human protein C». Proceedings of the National Academy of Sciences of the United States of America. 82 (14): 4673–7. PMC 390448
. PMID 2991887. doi:10.1073/pnas.82.14.4673 - Mosnier LO, Zlokovic BV, Griffin JH (abril de 2007). «The cytoprotective protein C pathway». Blood. 109 (8): 3161–72. PMID 17110453. doi:10.1182/blood-2006-09-003004
- Eichacker PQ, Natanson C, Danner RL (outubro de 2006). «Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly». The New England Journal of Medicine. 355 (16): 1640–2. PMID 17050887. doi:10.1056/NEJMp068197
- Martí-Carvajal AJ, Solà I, Gluud C, Lathyris D, Cardona AF (12 de dezembro de 2012). «Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients». The Cochrane Database of Systematic Reviews. 12: CD004388. ISSN 1469-493X. PMID 23235609. doi:10.1002/14651858.CD004388.pub6
- Kylat, Ranjit; Ohlsson, Arne (18 de abril de 2012). «Recombinant human activated protein C for severe sepsis in neonates.». Cochrane Database of Systematic Reviews (4): CD005385. doi:10.1002/14651858.CD005385.pub3
- Kisiel W, Ericsson LH, Davie EW (novembro de 1976). «Proteolytic activation of protein C from bovine plasma». Biochemistry. 15 (22): 4893–900. PMID 990250. doi:10.1021/bi00667a022
- Mosnier LO, Griffin JH (2006). «Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities». Frontiers in Bioscience. 11: 2381–99. PMID 16720321. doi:10.2741/1977
- Kisiel W, Canfield WM, Ericsson LH, Davie EW (dezembro de 1977). «Anticoagulant properties of bovine plasma protein C following activation by thrombin». Biochemistry. 16 (26): 5824–31. PMID 588557. doi:10.1021/bi00645a029
- Vehar GA, Davie EW (fevereiro de 1980). «Preparation and properties of bovine factor VIII (antihemophilic factor)». Biochemistry. 19 (3): 401–10. PMID 7356933. doi:10.1021/bi00544a001
- Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C (novembro de 1981). «Deficiency of protein C in congenital thrombotic disease». The Journal of Clinical Investigation. 68 (5): 1370–3. PMC 370934. PMID 6895379. doi:10.1172/JCI110385
- Goldenberg NA, Manco-Johnson MJ (novembro de 2008). «Protein C deficiency». Haemophilia. 14 (6): 1214–21. PMID 19141162. doi:10.1111/j.1365-2516.2008.01838.x
- Beckmann RJ, Schmidt RJ, Santerre RF, Plutzky J, Crabtree GR, Long GL (julho de 1985). «The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs». Nucleic Acids Research. 13 (14): 5233–47. PMC 321861. PMID 2991859. doi:10.1093/nar/13.14.5233
- Taylor FB, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE (março de 1987). «Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon». The Journal of Clinical Investigation. 79 (3): 918–25. PMC 424237. PMID 3102560. doi:10.1172/JCI112902
- Dahlbäck B, Carlsson M, Svensson PJ (fevereiro de 1993). «Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C». Proceedings of the National Academy of Sciences of the United States of America. 90 (3): 1004–8. PMC 45799. PMID 8430067. doi:10.1073/pnas.90.3.1004
- Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (maio de 1994). «Mutation in blood coagulation factor V associated with resistance to activated protein C». Nature. 369 (6475): 64–7. PMID 8164741. doi:10.1038/369064a0
- PROWESS: recombinant Human Activated PROtein C Worldwide Evaluation in Severe Sepsis; Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ (março de 2001). «Efficacy and safety of recombinant human activated protein C for severe sepsis». The New England Journal of Medicine. 344 (10): 699–709. PMID 11236773. doi:10.1056/NEJM200103083441001
- Hosac AM (abril de 2002). «Drotrecogin alfa (activated): the first FDA-approved treatment for severe sepsis». Proceedings. 15 (2): 224–7. PMC 1276518. PMID 16333441. doi:10.1080/08998280.2002.11927844
- Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W (junho de 2002). «Activation of endothelial cell protease activated receptor 1 by the protein C pathway». Science. 296 (5574): 1880–2. PMID 12052963. doi:10.1126/science.1071699
- Wildhagen KC, Lutgens E, Loubele ST, ten Cate H, Nicolaes GA (dezembro de 2011). «The structure-function relationship of activated protein C. Lessons from natural and engineered mutations». Thrombosis and Haemostasis. 106 (6): 1034–45. PMID 22072231. doi:10.1160/TH11-08-0522
- D'Ursi P, Marino F, Caprera A, Milanesi L, Faioni EM, Rovida E (2007). «ProCMD: a database and 3D web resource for protein C mutants». BMC Bioinformatics. 8 Suppl 1: S11. PMC 1885840. PMID 17430555. doi:10.1186/1471-2105-8-S1-S11
- Weiler-Guettler H, Christie PD, Beeler DL, Healy AM, Hancock WW, Rayburn H, Edelberg JM, Rosenberg RD (maio de 1998). «A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state». The Journal of Clinical Investigation. 101 (9): 1983–91. PMC 508785. PMID 9576763. doi:10.1172/JCI2006
- Gu JM, Crawley JT, Ferrell G, Zhang F, Li W, Esmon NL, Esmon CT (novembro de 2002). «Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality». The Journal of Biological Chemistry. 277 (45): 43335–43. PMID 12218060. doi:10.1074/jbc.M207538200
- Esmon CT (setembro de 2003). «The protein C pathway». Chest. 124 (3 Suppl): 26S-32S. PMID 12970121. doi:10.1378/chest.124.3_suppl.26S
- Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS (abril de 1993). «Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease». The Journal of Clinical Investigation. 91 (4): 1721–30. PMC 288152. PMID 8386194. doi:10.1172/JCI116382
- España F, Berrettini M, Griffin JH (agosto de 1989). «Purification and characterization of plasma protein C inhibitor». Thrombosis Research. 55 (3): 369–84. PMID 2551064. doi:10.1016/0049-3848(89)90069-8
- Nicolaes GA, Tans G, Thomassen MC, Hemker HC, Pabinger I, Varadi K, Schwarz HP, Rosing J (setembro de 1995). «Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C». The Journal of Biological Chemistry. 270 (36): 21158–66. PMID 7673148. doi:10.1074/jbc.270.36.21158
- Nicolaes GA, Bock PE, Segers K, Wildhagen KC, Dahlbäck B, Rosing J (julho de 2010). «Inhibition of thrombin formation by active site mutated (S360A) activated protein C». The Journal of Biological Chemistry. 285 (30): 22890–900. PMC 2906281. PMID 20484050. doi:10.1074/jbc.M110.131029
- Wildhagen KC, Schrijver R, Beckers L, ten Cate H, Reutelingsperger CP, Lutgens E, Nicolaes GA (julho de 2014). «Effects of exogenous recombinant APC in mouse models of ischemia reperfusion injury and of atherosclerosis». PLoS One. 9 (7): e101446. PMC 4102480. PMID 25032959. doi:10.1371/journal.pone.0101446
- Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G (junho de 2008). «Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)». Chest. 133 (6 Suppl): 160S-198S. PMID 18574265. doi:10.1378/chest.08-0670
- Dahlbäck B (janeiro de 2003). «The discovery of activated protein C resistance». Journal of Thrombosis and Haemostasis. 1 (1): 3–9. PMID 12871530. doi:10.1046/j.1538-7836.2003.00016.x
- Gillrie MR, Lee K, Gowda DC, Davis SP, Monestier M, Cui L, Hien TT, Day NP, Ho M (março de 2012). «Plasmodium falciparum histones induce endothelial proinflammatory response and barrier dysfunction». The American Journal of Pathology. 180 (3): 1028–39. PMC 3448071. PMID 22260922. doi:10.1016/j.ajpath.2011.11.037
- Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, François B, Guy JS, Brückmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N, Utterback BG, Macias WL (setembro de 2005). «Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death». The New England Journal of Medicine. 353 (13): 1332–41. PMID 16192478. doi:10.1056/NEJMoa050935
- Martí-Carvajal AJ, Solà I, Lathyris D, Cardona AF (13 de abril de 2011). Martí-Carvajal AJ, ed. «Human recombinant activated protein C for severe sepsis». The Cochrane Database of Systematic Reviews (4): CD004388. PMID 21491390. doi:10.1002/14651858.CD004388.pub4
- Griffin JH, Fernández JA, Mosnier LO, Liu D, Cheng T, Guo H, Zlokovic BV (2006). «The promise of protein C». Blood Cells, Molecules & Diseases. 36 (2): 211–6. PMID 16464623. doi:10.1016/j.bcmd.2005.12.023
nih.gov
ncbi.nlm.nih.gov
- Nicolaes GA, Dahlbäck B (fevereiro de 2003). «Congenital and acquired activated protein C resistance». Seminars in Vascular Medicine. 3 (1): 33–46. PMID 15199491. doi:10.1055/s-2003-38331
- Foster DC, Yoshitake S, Davie EW (julho de 1985). «The nucleotide sequence of the gene for human protein C». Proceedings of the National Academy of Sciences of the United States of America. 82 (14): 4673–7. PMC 390448. PMID 2991887. doi:10.1073/pnas.82.14.4673
- Mosnier LO, Zlokovic BV, Griffin JH (abril de 2007). «The cytoprotective protein C pathway». Blood. 109 (8): 3161–72. PMID 17110453. doi:10.1182/blood-2006-09-003004
- Eichacker PQ, Natanson C, Danner RL (outubro de 2006). «Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly». The New England Journal of Medicine. 355 (16): 1640–2. PMID 17050887. doi:10.1056/NEJMp068197
- Martí-Carvajal AJ, Solà I, Gluud C, Lathyris D, Cardona AF (12 de dezembro de 2012). «Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients». The Cochrane Database of Systematic Reviews. 12: CD004388. ISSN 1469-493X. PMID 23235609. doi:10.1002/14651858.CD004388.pub6
- Stenflo J (janeiro de 1976). «A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization». The Journal of Biological Chemistry. 251 (2): 355–63. PMID 1245477
- Kisiel W, Ericsson LH, Davie EW (novembro de 1976). «Proteolytic activation of protein C from bovine plasma». Biochemistry. 15 (22): 4893–900. PMID 990250. doi:10.1021/bi00667a022
- Mosnier LO, Griffin JH (2006). «Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities». Frontiers in Bioscience. 11: 2381–99. PMID 16720321. doi:10.2741/1977
- Kisiel W, Canfield WM, Ericsson LH, Davie EW (dezembro de 1977). «Anticoagulant properties of bovine plasma protein C following activation by thrombin». Biochemistry. 16 (26): 5824–31. PMID 588557. doi:10.1021/bi00645a029
- Vehar GA, Davie EW (fevereiro de 1980). «Preparation and properties of bovine factor VIII (antihemophilic factor)». Biochemistry. 19 (3): 401–10. PMID 7356933. doi:10.1021/bi00544a001
- Walker FJ (junho de 1980). «Regulation of activated protein C by a new protein. A possible function for bovine protein S». The Journal of Biological Chemistry. 255 (12): 5521–4. PMID 6892911
- Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C (novembro de 1981). «Deficiency of protein C in congenital thrombotic disease». The Journal of Clinical Investigation. 68 (5): 1370–3. PMC 370934. PMID 6895379. doi:10.1172/JCI110385
- Goldenberg NA, Manco-Johnson MJ (novembro de 2008). «Protein C deficiency». Haemophilia. 14 (6): 1214–21. PMID 19141162. doi:10.1111/j.1365-2516.2008.01838.x
- Beckmann RJ, Schmidt RJ, Santerre RF, Plutzky J, Crabtree GR, Long GL (julho de 1985). «The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs». Nucleic Acids Research. 13 (14): 5233–47. PMC 321861. PMID 2991859. doi:10.1093/nar/13.14.5233
- Taylor FB, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE (março de 1987). «Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon». The Journal of Clinical Investigation. 79 (3): 918–25. PMC 424237. PMID 3102560. doi:10.1172/JCI112902
- Dahlbäck B, Carlsson M, Svensson PJ (fevereiro de 1993). «Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C». Proceedings of the National Academy of Sciences of the United States of America. 90 (3): 1004–8. PMC 45799. PMID 8430067. doi:10.1073/pnas.90.3.1004
- Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (maio de 1994). «Mutation in blood coagulation factor V associated with resistance to activated protein C». Nature. 369 (6475): 64–7. PMID 8164741. doi:10.1038/369064a0
- Esmon NL, DeBault LE, Esmon CT (maio de 1983). «Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C». The Journal of Biological Chemistry. 258 (9): 5548–53. PMID 6304092
- PROWESS: recombinant Human Activated PROtein C Worldwide Evaluation in Severe Sepsis; Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ (março de 2001). «Efficacy and safety of recombinant human activated protein C for severe sepsis». The New England Journal of Medicine. 344 (10): 699–709. PMID 11236773. doi:10.1056/NEJM200103083441001
- Hosac AM (abril de 2002). «Drotrecogin alfa (activated): the first FDA-approved treatment for severe sepsis». Proceedings. 15 (2): 224–7. PMC 1276518. PMID 16333441. doi:10.1080/08998280.2002.11927844
- Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W (junho de 2002). «Activation of endothelial cell protease activated receptor 1 by the protein C pathway». Science. 296 (5574): 1880–2. PMID 12052963. doi:10.1126/science.1071699
- Wildhagen KC, Lutgens E, Loubele ST, ten Cate H, Nicolaes GA (dezembro de 2011). «The structure-function relationship of activated protein C. Lessons from natural and engineered mutations». Thrombosis and Haemostasis. 106 (6): 1034–45. PMID 22072231. doi:10.1160/TH11-08-0522
- D'Ursi P, Marino F, Caprera A, Milanesi L, Faioni EM, Rovida E (2007). «ProCMD: a database and 3D web resource for protein C mutants». BMC Bioinformatics. 8 Suppl 1: S11. PMC 1885840. PMID 17430555. doi:10.1186/1471-2105-8-S1-S11
- Weiler-Guettler H, Christie PD, Beeler DL, Healy AM, Hancock WW, Rayburn H, Edelberg JM, Rosenberg RD (maio de 1998). «A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state». The Journal of Clinical Investigation. 101 (9): 1983–91. PMC 508785. PMID 9576763. doi:10.1172/JCI2006
- Gu JM, Crawley JT, Ferrell G, Zhang F, Li W, Esmon NL, Esmon CT (novembro de 2002). «Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality». The Journal of Biological Chemistry. 277 (45): 43335–43. PMID 12218060. doi:10.1074/jbc.M207538200
- Esmon CT (setembro de 2003). «The protein C pathway». Chest. 124 (3 Suppl): 26S-32S. PMID 12970121. doi:10.1378/chest.124.3_suppl.26S
- Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS (abril de 1993). «Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease». The Journal of Clinical Investigation. 91 (4): 1721–30. PMC 288152. PMID 8386194. doi:10.1172/JCI116382
- España F, Berrettini M, Griffin JH (agosto de 1989). «Purification and characterization of plasma protein C inhibitor». Thrombosis Research. 55 (3): 369–84. PMID 2551064. doi:10.1016/0049-3848(89)90069-8
- Nicolaes GA, Tans G, Thomassen MC, Hemker HC, Pabinger I, Varadi K, Schwarz HP, Rosing J (setembro de 1995). «Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C». The Journal of Biological Chemistry. 270 (36): 21158–66. PMID 7673148. doi:10.1074/jbc.270.36.21158
- Nicolaes GA, Bock PE, Segers K, Wildhagen KC, Dahlbäck B, Rosing J (julho de 2010). «Inhibition of thrombin formation by active site mutated (S360A) activated protein C». The Journal of Biological Chemistry. 285 (30): 22890–900. PMC 2906281. PMID 20484050. doi:10.1074/jbc.M110.131029
- Wildhagen KC, Schrijver R, Beckers L, ten Cate H, Reutelingsperger CP, Lutgens E, Nicolaes GA (julho de 2014). «Effects of exogenous recombinant APC in mouse models of ischemia reperfusion injury and of atherosclerosis». PLoS One. 9 (7): e101446. PMC 4102480. PMID 25032959. doi:10.1371/journal.pone.0101446
- Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G (junho de 2008). «Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)». Chest. 133 (6 Suppl): 160S-198S. PMID 18574265. doi:10.1378/chest.08-0670
- Dahlbäck B (janeiro de 2003). «The discovery of activated protein C resistance». Journal of Thrombosis and Haemostasis. 1 (1): 3–9. PMID 12871530. doi:10.1046/j.1538-7836.2003.00016.x
- Gillrie MR, Lee K, Gowda DC, Davis SP, Monestier M, Cui L, Hien TT, Day NP, Ho M (março de 2012). «Plasmodium falciparum histones induce endothelial proinflammatory response and barrier dysfunction». The American Journal of Pathology. 180 (3): 1028–39. PMC 3448071. PMID 22260922. doi:10.1016/j.ajpath.2011.11.037
- Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, François B, Guy JS, Brückmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N, Utterback BG, Macias WL (setembro de 2005). «Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death». The New England Journal of Medicine. 353 (13): 1332–41. PMID 16192478. doi:10.1056/NEJMoa050935
- Martí-Carvajal AJ, Solà I, Lathyris D, Cardona AF (13 de abril de 2011). Martí-Carvajal AJ, ed. «Human recombinant activated protein C for severe sepsis». The Cochrane Database of Systematic Reviews (4): CD004388. PMID 21491390. doi:10.1002/14651858.CD004388.pub4
- Martí-Carvajal AJ1, Solà I, Gluud C, Lathyris D, Cardona AF. Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients.Cochrane Database Syst Rev. 2012 Dec 12;12:CD004388. doi: 10.1002/14651858.CD004388.pub6. PMID 23235609 update
- Griffin JH, Fernández JA, Mosnier LO, Liu D, Cheng T, Guo H, Zlokovic BV (2006). «The promise of protein C». Blood Cells, Molecules & Diseases. 36 (2): 211–6. PMID 16464623. doi:10.1016/j.bcmd.2005.12.023
worldcat.org
- Martí-Carvajal AJ, Solà I, Gluud C, Lathyris D, Cardona AF (12 de dezembro de 2012). «Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients». The Cochrane Database of Systematic Reviews. 12: CD004388. ISSN 1469-493X. PMID 23235609. doi:10.1002/14651858.CD004388.pub6